Search clinical trials for: Scaphoid nonunion advanced collapse

Total 23264 results

ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer

Adenocarcinoma | Pancreatic Cancer

United States
Threshold Pharmaceuticals

Completed

Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors

Breast Cancer | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Lung Cancer

United States
Sanofi

Completed

Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer

Stomach Neoplasm
Threshold Pharmaceuticals

Terminated

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Sanofi

Completed

Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer

Cancer

United States, France, Canada, Russian Federation, Portugal, Argentina
ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

ARQ 501 in Combination With Docetaxel in Patients With Cancer

Carcinoma

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus

Adenocarcinoma of Stomach | Adenocarcinoma of GE Junction | Adenocarcinoma of Esophagus

United States
Pharmasset

Terminated

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus (QUASH2)

Hepatitis B | Chronic Hepatitis

United States, Canada, China, Argentina, Taiwan, Spain, Puerto Rico, Australia, Greece, Thailand, United Kingdom
Pharmasset

Terminated

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus (QUASH 1)

Hepatitis B | Chronic Hepatitis

United States, Canada, Argentina, Taiwan, Spain, Puerto Rico, Australia, Greece, Thailand, United Kingdom, Brazil, China
AstraZeneca

Completed

IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma

Cancer of Head and Neck

Spain
AstraZeneca

Completed

IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Spain
AstraZeneca

Terminated

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC

Finland
AstraZeneca

Completed

A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer

Breast Cancer

Spain
AstraZeneca

Completed

Phase II Iressa Versus Vinorelbine (INVITE)

Non-Small-Cell Lung Carcinoma

Czech Republic, Italy, Korea, Republic of, South Africa, United Kingdom, Germany, Australia, Taiwan, France, Brazil
AstraZeneca

Completed

IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

Colorectal Cancer

Spain
AstraZeneca

Completed

Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic (AGUS)

Tumors

United States
National Institute of Cancerología

Unknown

Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer

Locally Advanced Non Small-Cell Lung Canger

Mexico
Merck Sharp & Dohme LLC

Completed

Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors

Advanced Cancer
AstraZeneca

Terminated

Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients (FORUM)

Breast Cancer

Netherlands
Sanofi

Completed

Obese Patients With Type 2 Diabetes (RIO-Diabetes)

Obesity | Diabetes Mellitus, Non-Insulin-Dependent | Obesity in Diabetes

United States, France, Canada, Poland, Germany, Netherlands, Belgium, Czech Republic, Argentina, Finland, United Kingdom
Sanofi

Completed

Obese Patients With or Without Comorbidities (RIO-North America)

Obesity | Weight Loss

United States, Canada
Nanjing Sike Pharmaceutical Co., Ltd.

Unknown

Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma

Advanced Gastric Carcinoma
Antisoma Research

Completed

Study of AS1411 in Advanced Solid Tumours

Advanced Solid Tumors

United States
Nanjing Sike Pharmaceutical Co., Ltd.

Unknown

Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma

Gastric Carcinoma

China
University Hospital, Antwerp
Eli Lilly and Company; Universiteit Antwerpen

Completed

Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (PACCORA)

Non-Small Cell Lung Cancer

Belgium
AstraZeneca

Completed

Second Line Breast Cancer Trial

Advanced Breast Cancer
Amgen

Completed

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Non-Small Cell Lung Cancer
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Gastrointestinal Neoplasms | Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms

United States
Pharmacyclics LLC.

Completed

A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Bronchogenic | Non-Small-Cell Lung Carcinoma

United States
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Completed

Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract

Biliary Tract Disease

Taiwan
La Jolla Pharmaceutical Company

Terminated

Study of LJP 394 in Lupus Patients With History of Renal Disease (ASPEN)

Lupus Erythematosus, Systemic | Lupus Nephritis

Taiwan, United States, Belarus, Serbia, Czech Republic, Philippines, Lebanon, India, Korea, Republic of, Argentina, Australia, Brazil, Bulgaria, Georgia, Germany, Hong Kong, Hungary, Indonesia, Italy, Malaysia, Mexico, Poland, Portugal and more
Nanjing Medical University

Completed

Evaluation of Different Anesthesia for Uterine Curettage (EDAUC)

Abortion, Induced | Uterine Curettage

China
Advanced Specialty Care

Unknown

The Effects of Exenatide After Gastric Restriction (AGREE)

Morbid Obesity

United States
Sanofi

Completed

Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function (FOLFOX4)

Gastrointestinal Cancer

United States
Gruppo Italiano Studio Linfomi

Completed

Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) (HD2000)

Advanced Hodgkin Disease

Italy
Pfizer

Terminated

MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Lowcountry Infectious Diseases

Unknown

Neuroma Injections to Treat Restless Legs Syndrome - RCT

Restless Legs Syndrome

United States
Synta Pharmaceuticals Corp.

Suspended

A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors

Metastatic Solid Tumors

United States
Zhejiang University
Odense University Hospital

Completed

The Infected Bone Nonunion and Soft Tissue Defect of Long Bone Treated Simultaneously With Ilizarov Technique

Trauma | Orthopedic Surgery Complications

China
Free University Medical Center

Unknown

Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Netherlands
Swedish Orphan Biovitrum
Amgen

Withdrawn

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Head and Neck Cancer
Italian Trial in Medical Oncology

Completed

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC) (ROSORC)

Renal Cell Carcinoma | Metastatic Disease

Italy
Italian Trial in Medical Oncology

Completed

Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) (P2)

Hepatocellular Carcinoma

Italy
Advanced Ophthalmic Pharma

Withdrawn

Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops

Cataract
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Cell Genesys

Unknown

GVAX in Advanced Prostate Cancer Patients Made Lymphopenic

Prostate Cancer

United States
Adnexus, A Bristol-Myers Squibb R&D Company

Completed

CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma

Cancer

United States
Fudan University

Completed

Radiation Dose Escalation Study for Advanced Liver Cancer

Hepatocellular Carcinoma
Anza Therapeutics, Inc.

Terminated

Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus

Chronic Hepatitis C

United States
Anza Therapeutics, Inc.

Terminated

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Carcinoma, Non-Small-Cell Lung | Adenocarcinoma of the Pancreas | Malignant Epithelial Mesothelioma | Adenocarcinoma of the Ovaries

Israel, United States
Fudan University

Unknown

Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer

Local Advanced Non-Small Cell Lung Cancer

China

Search clinical trials for: Scaphoid nonunion advanced collapse

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations